Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
41
NCT02371746
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 1, 2015
Completion: Feb 13, 2019